Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. - Wikidata - awgldk - TriplyDB

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

http://www.wikidata.org/entity/Q35011883

about

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice MicroRNAs in platelet production and activation Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms miR-145-mediated suppression of cell growth, invasion and metastasis Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype Immune Mechanisms in Myelodysplastic Syndrome Genomic landscape of megakaryopoiesis and platelet function defects The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis MicroRNAs and the resolution phase of inflammation in macrophages Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research IRAK signalling in cancer Role of microRNA-146a in normal and malignant hematopoietic stem cell function Deconstructing innate immune signaling in myelodysplastic syndromes Tumor suppressor microRNAs: a novel non-coding alliance against cancer MicroRNAs: new regulators of Toll-like receptor signalling pathways Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway miRNA dysregulation in cancer: towards a mechanistic understanding PP2A: The Achilles Heal in MDS with 5q Deletion The Role of Toll-Like Receptors in Hematopoietic Malignancies Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice NPM1 deletion is associated with gross chromosomal rearrangements in leukemia Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.Evaluation of TRAF6 in a large multiancestral lupus cohort Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.[Myelodysplastic syndromes].Myelodysplastic syndromes: Contemporary review and how we treat.Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia Toll-like receptor alterations in myelodysplastic syndrome SRF is required for neutrophil migration in response to inflammation.Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia Emerging roles for natural microRNA sponges.Ribosomopathies: human disorders of ribosome dysfunction.Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.

P2860

Q24595073-C39B12D3-E33F-46BE-A921-A5E92C95A14B Q24622537-0DAEAE18-04AE-446C-9DC8-EEEDD6B1EEE4 Q24622802-345635FF-637E-4C54-8963-74A9BB55C041 Q24629306-A9498915-6095-4F58-8622-B58F95A62A54 Q24634704-0B540323-5B7E-43D4-9E20-06161A7DBE3E Q26744481-3664FC5B-EEAB-4A43-A374-9961C1E38E74 Q26744500-8F808031-1CBC-40E1-8A78-75051D89374A Q26770869-57C22E1F-50E1-4A23-8936-798C027FA05E Q26800055-57C28997-8358-42C4-8E53-F090566FE5E8 Q26821845-7CF72FBE-5DA6-42A8-974A-78786FAE1E11 Q26828777-11259611-5A34-4905-8938-699FCCAA319E Q26830890-1FCFF44B-8447-46B6-89B8-3E4D387E9774 Q26859843-79E97DBA-7556-41D2-A414-8373F8DA88E7 Q26863735-C28ACF63-1D07-454A-BB4D-0ABBD86DCE48 Q26864607-0BCAB154-1945-4A94-86F4-BEC70CA339DC Q26991974-7FA2E02F-85BE-4658-9BFF-082060E89452 Q26995383-C99EF49D-5CD4-4761-91F4-565F778EBC5D Q27010055-6DC6A310-099E-4F13-ADAF-FED446EFA6B2 Q27015288-411DC9AA-895D-42CD-97B3-5C468B5326F1 Q27022918-928C60B5-E569-4D32-9B22-7006467C0F06 Q27026420-A04F4992-4F83-48E8-B361-943686E022FE Q27690852-5ED9E07B-1E8B-4D5E-9EC5-CC96CF24AB8A Q28077740-4A6825D6-E455-4113-83CA-19EB421B2F39 Q28114815-F9340AB7-2350-4620-AD55-A6CA3EF52C38 Q28749228-2CB4426A-AC04-4B1D-B8B6-2B9B1671BEFF Q30397539-33A10554-2F2C-400B-B1FD-08F797FCB46B Q30500885-9323B9F6-164B-42A3-9FCB-283B1DBF277D Q31145646-92B67607-8336-40E8-974F-A8800FE31DCC Q33399089-23D7FCDB-5353-47A2-8E41-9CF92A40CF5C Q33407110-DE984301-F582-4689-8887-AB0BDEFF6019 Q33420574-1784DA78-2EAE-4CE3-8C50-EE91AEC0859E Q33429195-0B55FDDA-EB12-4401-B29D-B9B9A7DF8DA6 Q33558976-D4247597-9644-4CC7-A827-50DD1AA7F3F0 Q33572616-573E683D-E174-4A3D-A80D-3B1F12FC8177 Q33585299-D80975C9-636A-473A-A238-5EA57652A8F6 Q33652652-DE99080C-EBB0-44EB-A079-5E9EEDB2ED55 Q33796552-3241DD9D-02D0-4779-A0B3-BE80ED262AE2 Q33805820-4433C239-3132-452E-9133-ED1D207037C8 Q33806050-6838D845-E437-4C2A-9900-EFEB8AFBE9F4 Q33814453-69CFB3AE-E955-4012-8B26-580A56DC4F9B

P2860

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

http://www.wikidata.org/entity/Q35011883

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@ast

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@en

type

label

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@ast

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@en

prefLabel

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@ast

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@en

P1433

Q35011883-9A8D0624-A607-47CB-B782-C8A4A17C4B9B

P1476

Q35011883-3F394E47-13DE-46A6-800D-62BCCD8B23FF

P2093

Q35011883-156DA258-D16F-4DC3-B16F-613BFD47270B

Q35011883-5BEE8A30-629E-431F-A351-A96665D71FC9

Q35011883-658CA92F-CE42-4049-B5C0-4124F0E2F887

Q35011883-694EEB90-FECB-4198-B654-178107DEF0B1

Q35011883-6CA5E8F7-1B61-458D-B11A-466FC1A9467D

Q35011883-83FFA2F8-0987-4179-A1EA-155D7027A87E

Q35011883-957A6D88-084A-437B-BEF1-A9EF9BB988B1

Q35011883-AB1BEE3E-E061-46E9-95BC-53100F792F0F

Q35011883-BE92954D-F5A5-4F08-867C-95DCFFFF3E8B

Q35011883-D4F088C4-BB29-4E53-B853-1E47318A5AC6

P2888

Q35011883-526E9B8F-12FC-4947-A279-ACE768F8A637

P304

Q35011883-30A92CCB-F430-43B1-BABD-233B1497EAAC

P31

Q35011883-7EE81920-1038-42C5-8BDE-1689335913C4

P356

Q35011883-395A7690-65E9-4A1E-9E75-92BF6F9F1556

P407

Q35011883-E6631158-404B-4103-ABE8-693776415038

P433

Q35011883-4D9DD5F2-CFC9-4688-A48E-1B194C9D16B6

P478

Q35011883-C675026C-0A3A-4993-B157-9971FA349354

P50

Q35011883-0B7B437A-8900-4700-922E-FAAB686CC0EC

Q35011883-97F29B3B-471E-4DAD-8D93-98A4E0A7F3B3

P577

Q35011883-CE62A637-7481-42D1-A5AA-7BAC1926E67D

P5875

Q35011883-40361BD0-1DBD-4764-85C3-035CBDC2AE17

P6179

Q35011883-FF520D3A-2907-4097-828C-59F6668C569F

P698

Q35011883-717FD472-8748-4C6D-9ED6-EF0145A0FDCC

P356

P1433

Nature Medicine

P1476

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

@en

P2093

Aly Karsan

http://www.w3.org/2001/XMLSchema#string

Andrew Muranyi

http://www.w3.org/2001/XMLSchema#string

Bob Argiropoulos

http://www.w3.org/2001/XMLSchema#string

Daniel T Starczynowski

http://www.w3.org/2001/XMLSchema#string

Donna Hogge

http://www.w3.org/2001/XMLSchema#string

Florian Kuchenbauer

http://www.w3.org/2001/XMLSchema#string

Marco Marra

http://www.w3.org/2001/XMLSchema#string

Martin Hirst

http://www.w3.org/2001/XMLSchema#string

Rena Buckstein

http://www.w3.org/2001/XMLSchema#string

Richard A Wells

http://www.w3.org/2001/XMLSchema#string

P2888

P304

49-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2054

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

R Keith Humphries

P577

2009-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38075404

http://www.w3.org/2001/XMLSchema#string

P6179

1021915407

http://www.w3.org/2001/XMLSchema#string

P698

19898489

http://www.w3.org/2001/XMLSchema#string